Skip to search boxSkip to navigationSkip to main content

Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo

  • Casey N. Bassett(corresponding author)
    ,
  • M. Diana Neely
    ,
  • Kathrin R. Sidell
    ,
  • William R. Markesbery
    ,
  • Larry L. Swift
    ,
  • Thomas J. Montine
*Corresponding author for this work
  • Vanderbilt University
    ,
  • University of Kentucky
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Brain regional oxidative damage is thought to be a central mechanism in the pathogenesis of Alzheimer's disease (AD). Recent studies of cerebrospinal fluid (CSF) have suggested that increased lipid peroxidation of CSF and CSF lipoproteins also may occur in AD patients. In the present study, we determined the susceptibility of human CSF to ex vivo lipid peroxidation and tested the hypothesis that oxidized CSF lipoproteins may be neurotoxic. Whole CSF or a CSF lipoprotein fraction (d < 1.210 g/mL) was oxidized with 2,2'- azobis(2-amidinopropane)dihydrochloride (AAPH), a hydrophilic free-radical generator. Kinetics of CSF lipid peroxidation were followed by a standard fluorescence product accumulation assay. Oxidation of AD CSF yielded significantly shorter fluorescent lag times than controls, indicating reduced antioxidant capacity. Electrophoretic mobilities of CSF apolipoproteins were specifically reduced upon oxidation of CSF with AAPH, suggesting that lipoproteins are primary targets of CSF lipid peroxidation. Cultured neuronal cells were exposed to physiological concentrations of isolated CSF lipoproteins oxidized with increasing concentrations of AAPH; the resulting neurotoxicity showed a significant linear AAPH concentration-response relationship. These results suggest that oxidized CSF lipoproteins may contribute to the pathogenesis of neurodegeneration in AD.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1273-1280 (8 pages)

Journal (Volume, Issue Number)

Lipids (Volume 34, Issue 12)

Publication milestones

  • Published - 1999

Publication status

Published - 1999

ISSN

0024-4201

Publication IDs

  • Scopus: 0033374599
  • PubMed: 10652986

Publication metrics

Metrics

SciVal
FWCI
2.03
SciVal
Author count
6
SciVal
citations
51
SciVal
Paper percentile
86
Scopus
citations
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
30
Citation count
57
Mentions
1

Funding Details

We wish to express our gratitude to Cecil Runyons for his expert assistance. This work was supported by NIH grants AG00774, AG16835, AG05144, AG05119, DK26657, and a training grant, GM08554, as well as grants from the Abercrombie Foundation, the American Federation for Aging Research, and the Alzheimer’s Disease and Related Disorders Association.
FundersFunding numbers
NIH
DK26657, AG05119, AG00774, GM08554, AG05144
NIA
R01AG016835
AA
-
AFAR
-
Abercrombie Foundation
-